Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D Culler

Showing results (61-70 of 82) with videos related to

Pageof 9
Sort By:
Endocrinology|May 28, 2005
Endogenous ghrelin regulates episodic growth hormone (GH) secretion by amplifying GH Pulse amplitude: evidence from antagonism of the GH secretagogue-R1a receptorP Zizzari, H Halem, J Taylor, et al.
The Journal of Clinical Endocrinology and Metabolism|December 6, 2002
Demonstration of enhanced potency of a chimeric somatostatin-dopamine molecule, BIM-23A387, in suppressing growth hormone and prolactin secretion from human pituitary somatotroph adenoma cellsA Saveanu, E Lavaque, G Gunz, et al.
Human Reproduction (Oxford, England)|December 24, 1997
Ontogeny of gonadotrophin and inhibin secretion in normal girls through puberty based on overnight serial sampling and a comparison with normal boysP K Manasco, D M Umbach, S M Muly, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1995
Ontogeny of gonadotropin, testosterone, and inhibin secretion in normal boys through puberty based on overnight serial samplingP K Manasco, D M Umbach, S M Muly, et al.
European Journal of Endocrinology|July 5, 2005
Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapyP Jaquet, G Gunz, A Saveanu, et al.
Journal of Endocrinological Investigation|April 22, 2006
BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotideP Jaquet, G Gunz, A Saveanu, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomasA Saveanu, G Gunz, H Dufour, et al.
Peptides|January 1, 1983
In vitro pituitary hormone releasing activity of 40 residue human pancreatic tumor growth hormone releasing factorA Arimura, M D Culler, C M Turkelson, et al.
Cell Death and Differentiation|April 29, 2006
Novel synergistic mechanism for sst2 somatostatin and TNFalpha receptors to induce apoptosis: crosstalk between NF-kappaB and JNK pathwaysJ Guillermet-Guibert, N Saint-Laurent, L Davenne, et al.
The Journal of Endocrinology|September 30, 2010
Somatostatin and dopamine receptor interaction in prostate and lung cancer cell linesM Arvigo, F Gatto, M Ruscica, et al.
Pageof 9

Showing results (61-70 of 82) with videos related to

Sort By:
Pageof 9
Endocrinology|May 28, 2005
Endogenous ghrelin regulates episodic growth hormone (GH) secretion by amplifying GH Pulse amplitude: evidence from antagonism of the GH secretagogue-R1a receptorP Zizzari, H Halem, J Taylor, et al.
The Journal of Clinical Endocrinology and Metabolism|December 6, 2002
Demonstration of enhanced potency of a chimeric somatostatin-dopamine molecule, BIM-23A387, in suppressing growth hormone and prolactin secretion from human pituitary somatotroph adenoma cellsA Saveanu, E Lavaque, G Gunz, et al.
Human Reproduction (Oxford, England)|December 24, 1997
Ontogeny of gonadotrophin and inhibin secretion in normal girls through puberty based on overnight serial sampling and a comparison with normal boysP K Manasco, D M Umbach, S M Muly, et al.
The Journal of Clinical Endocrinology and Metabolism|July 1, 1995
Ontogeny of gonadotropin, testosterone, and inhibin secretion in normal boys through puberty based on overnight serial samplingP K Manasco, D M Umbach, S M Muly, et al.
European Journal of Endocrinology|July 5, 2005
Efficacy of chimeric molecules directed towards multiple somatostatin and dopamine receptors on inhibition of GH and prolactin secretion from GH-secreting pituitary adenomas classified as partially responsive to somatostatin analog therapyP Jaquet, G Gunz, A Saveanu, et al.
Journal of Endocrinological Investigation|April 22, 2006
BIM-23A760, a chimeric molecule directed towards somatostatin and dopamine receptors, vs universal somatostatin receptors ligands in GH-secreting pituitary adenomas partial responders to octreotideP Jaquet, G Gunz, A Saveanu, et al.
The Journal of Clinical Endocrinology and Metabolism|March 7, 2001
Bim-23244, a somatostatin receptor subtype 2- and 5-selective analog with enhanced efficacy in suppressing growth hormone (GH) from octreotide-resistant human GH-secreting adenomasA Saveanu, G Gunz, H Dufour, et al.
Peptides|January 1, 1983
In vitro pituitary hormone releasing activity of 40 residue human pancreatic tumor growth hormone releasing factorA Arimura, M D Culler, C M Turkelson, et al.
Cell Death and Differentiation|April 29, 2006
Novel synergistic mechanism for sst2 somatostatin and TNFalpha receptors to induce apoptosis: crosstalk between NF-kappaB and JNK pathwaysJ Guillermet-Guibert, N Saint-Laurent, L Davenne, et al.
The Journal of Endocrinology|September 30, 2010
Somatostatin and dopamine receptor interaction in prostate and lung cancer cell linesM Arvigo, F Gatto, M Ruscica, et al.
Pageof 9